background preloader

Over implantaten - about medical devices (implants)

Facebook Twitter

A Shocking Diagnosis: Breast Implants ‘Gave Me Cancer’ - The Food and Drug Administration first reported a link between implants and the disease in 2011, and information was added to the products’ labeling.

A Shocking Diagnosis: Breast Implants ‘Gave Me Cancer’ -

But the added warnings are deeply embedded in a dense list of complications, and no implants have been recalled. The F.D.A. advises women only “to follow their doctor’s recommended actions for monitoring their breast implants,” a spokeswoman said in an email this month. Until recently, many doctors had never heard of the disease, and little was known about the women who suddenly received the shocking diagnosis of cancer brought on by implants. How are medical devices regulated in the European Union? Rethinking medical device regulation. Changing the paradigm of the physician-industry relationship. Dr Lee is a maternal-fetal medicine specialist at Northwest Perinatal Center/Women’s Healthcare Associates, LLC, Portland, Oregon.

Changing the paradigm of the physician-industry relationship

The National Academy of Medicine (formerly the Institute of Medicine [IOM]) 2001 landmark publication, Crossing the Quality Chasm: A New Health System for the 21st Century, boldly proclaimed that “between the health care we have and the care we could have lies not just a gap, but a chasm.” This report identified 6 characteristics of a better healthcare system: safe, effective, patient-centered, timely, efficient, and equitable. As physicians, we have all witnessed first-hand vast strides toward more standardized, evidence-based and patient-centric care. However, much of this progress has focused on the interactions between patients and their providers (eg, physicians, hospital systems) and less so on the global systems in which these interactions take place. A historical perspective. University of Minnesota study finds companies inclined to wait too long to recall medical devices.

Medical device companies, like the hundreds that dot Minnesota, do not know everything about the safety of their products.

University of Minnesota study finds companies inclined to wait too long to recall medical devices

The Food and Drug Administration requires device makers to prove new devices are safe to use as directed, but there’s only so much testing the agency can require before approving or denying a new product for market. That’s why the FDA requires “postmarket” surveillance, which includes investigating all complaints about their devices and reporting confirmed problems publicly.

But researchers and regulators say the device-surveillance system is deeply flawed, exposing patients and doctors to greater risks. Many device problems are never logged in the FDA’s public system for adverse-event reporting known as MAUDE. And a study published last month by University of Minnesota researchers found that even when device companies do have the relevant information at hand, they are often biased in favor of waiting too long to issue product recalls. 'Track en trace' voor implantaten. Door de nieuwsredactie · geplaatst: maandag 28 november 2016, 15:21 uur | update: 15:21 uur.

'Track en trace' voor implantaten

Medical Device Employees Are Often In The O.R., Raising Concerns About Influence. They are a little-known presence in many operating rooms, offering technical expertise to surgeons installing new knees, implanting cardiac defibrillators or performing delicate spine surgery.

Medical Device Employees Are Often In The O.R., Raising Concerns About Influence

Many “people who don’t work in health care don’t realize that industry reps are sometimes in the OR,” said Josephine Wergin, a risk management analyst for the ECRI Institute, a Pennsylvania nonprofit that conducts research on medical subjects for the health care industry. FDA is working with hospitals to modernize data collection about medical devices. Jeffrey Shuren, M.D., J.D., Director of FDA’s Center for Devices and Radiological Health By: Jeffrey Shuren, M.D., J.D.

FDA is working with hospitals to modernize data collection about medical devices

America’s hospitals and their dedicated staff helps us fight disease and suffering by delivering life-saving and life-enhancing care every day in an astounding variety of ways. From helping set a broken leg or responding to an emerging viral threat, to assisting and performing delicate heart surgeries on tiny newborns, these hospital personnel are the front line of surveillance, vigilance, and intervention. Faulty medical implants investigation: Patients being put at risk by implants scam, says Jeremy Hunt. Yesterday, it was revealed that British patients’ health is being put at risk because some European regulators, known as notified bodies, were prepared to license potentially dangerous medical implants.

Faulty medical implants investigation: Patients being put at risk by implants scam, says Jeremy Hunt

FDA Gets Closer to Better Medical Device Tracking. CMS reverses course, agrees to unique device identifiers (UDIs) despite unknown costs.

FDA Gets Closer to Better Medical Device Tracking

Documents considered by the Committee on 25 May 2016 - European Scrutiny Committee. Documents considered by the Committee on 25 May 2016 Contents Summary and Committee’s conclusions 4.1The term “medical devices” encompasses a vast array of products used for medical purposes, ranging from sticking plasters to hip replacements and pacemakers.

Documents considered by the Committee on 25 May 2016 - European Scrutiny Committee

The proposed Regulations would repeal and replace three existing Directives which establish the EU regulatory framework for medical devices. Urogynecologists speak: FDA reclassification welcome. A January 4th action by the US Food and Drug Administration (FDA) reclassified transvaginal mesh implants for pelvic organ prolapse (POP) as class III (or high-risk) medical devices requiring premarket approval application (PMA).

Urogynecologists speak: FDA reclassification welcome

The action followed numerous warnings from the FDA about the implants’ safety over the past 8 years. Transvaginal mesh implants were previously classified as class II (moderate risk) devices. Notably, the change applies only to surgical mesh marketed for transvaginal treatment of POP, and not the device’s use for indications such as stress urinary incontinence or abdominal repair of POP. Specifically, the change does not apply to full-length retropubic and transobturator midurethral slings or sacral colopopexy meshes, all of which have extensive clinical data showing safety and efficacy. Experts in urogynecology welcomed the change.

Gestest op Europeanen. Slecht getest op mensen. Will Congress choose to protect patients and doctors from dangerous devices? On June 8, 2016, a bipartisan bill was proposed by U.S. Representatives Mike Fitzpatrick (R-PA), Louise Slaughter (D-NY) and Ryan Zinke (R-MT). This bill, the “Medical Device Guardians Act” (H.R. 5404), was named in honor of the hundreds, if not thousands, of women whose lives were devastated or ended prematurely, using a flawed medical device known as a Power Morcellator. The Guardians Act targets a very serious defect in the FDA’s “self-reporting” requirements for medical devices. Current law requires that hospital corporations and manufacturers report adverse outcomes related to the use of medical devices to FDA. Therapeutic products regulatory regime. Therapeutic product is an umbrella term for products that are intended to be used in or on human beings for a therapeutic purpose. Examples of therapeutic purposes include bringing about a physiological response to prevent, diagnose, monitor, alleviate, treat, or cure a disease, ailment, defect, or injury.

Therapeutic products can present serious risks of harm, especially if used inappropriately. Assuring that the benefits of therapeutic products outweigh possible risks of harm to consumers is fundamental to the delivery of high quality health and disability support services. The Government is currently developing a new therapeutic products regulatory regime.

Oversight of Medical Device Safety not What it Should Be. Medical devices are intended to provide cures for health problems, but some may cause harm. And regulators not collecting the data that would help show the difference. According to a report from the Bookings Institution, known medical device problems contribute to about 3,000 deaths per year in the United States. But because health regulatory agencies do not track medical devices the way they track prescription drugs for quality and safety, there may be many more device-related deaths than are known, the New York Times reports. Problems with medical devices are not infrequent, the Times says. Device Recalls Escalate - Why? General Surgery News.pdf. Why Health Insurance Claims Data Needs Medical Device ID. Meet-160308-brazil-presentation-regulatory-updates-usa.

Nederlands Tijdschrift voor Geneeskunde. IMPLANT INDUSTRY IS FACING CUTBACK BY TOP SUPPLIERS. Big chemical companies and other manufacturers of materials used to make heart valves, artificial blood vessels and other implants have been quietly warning medical equipment companies that they intend to cut off deliveries because of fears of lawsuits. While the suppliers' new policies have not yet forced important products from the market, medical equipment makers that are scrambling to protect themselves from the impending cutoffs say they are having trouble lining up alternate suppliers.

Industry executives and doctors say that the trend could eventually make some life-saving implants hard to come by and have a devastating effect on development of new devices. About 100 equipment companies have already had supply problems, according to reports received by the Health Industry Manufacturers Association, the equipment makers' Washington-based trade group.

Ministers launch urgent inquiry into NHS officials' second jobs at drugs firms. A spokesman for NHS England said that the behaviour reported by the Telegraph was “unacceptable”. The NHS added that a proposed new standard contract for staff would introduce a requirement for any gifts and hospitality from drugs firms to be declared. The move "will make it easier to spot when NHS staff have a conflict of interest" and allow those in breach of the rules to face disciplinary and possibly criminal action. The proposed new contract comes after this newspaper previously exposed two officials being paid as middle-men to arrange lucrative advisory board meetings attended by NHS staff. Today's investigation, involving information from whistle-blowers and hundreds of Freedom of Information (FOI) requests, reveals that the practice of officials taking prescribing and “medicines management” roles while acting as consultants to drugs firms is systemic within the NHS.

The investigation found: q9133. Moet er een meldpunt komen voor bijwerkingen implantaten? MDDI Medical Device and Diagnostic Industry News Products and Suppliers. Polymer: Viscosity Testing. If you’ve ever had the thoroughly frustrating experience of trying to clean up spilled maple syrup off a floor, table or countertop, you’ve actually received a basic (albeit unpleasant) introduction to the concept of viscosity. Maple syrup is deucedly difficult to clean off virtually anything because it’s thick and sticky. If it were less thick — say the consistency of water or fruit juice — you could mop it up with a paper towel and call it done. Simply stated, viscosity is the measure of a fluid’s resistance to motion inspired by an outside force. In our maple syrup example, your hand and the paper towel represent the outside force. Because maple syrup has a high viscosity, the molecules in the syrup have a hard time moving past each other.

Abdominal surgery products meshes. Shocking Report from Medical Insiders. F. MDDI Medical Device and Diagnostic Industry News Products and Suppliers. General Surgery News Mobile. Review into PiP implants published. Vanessa's Law not helping boost drug safety, ER doctor says - Health. Canada's new drug safety law mandates hospitals to report serious drug reactions, but it needs to be strengthened because fewer than five per cent of the reports are ever filed, doctors say. A commentary in Monday's issue of the Canadian Medical Association Journal is titled "Can reporting of adverse drug events create safer systems while improving health data?

" Omzendbrief%20421%20NL%20Meldingsplicht%20incidenten_tcm290-27128.pdf. Zorgtaboe #22: Kwaliteit van medische hulpmiddelen: "What you see is what you get" Medische hulpmiddelen in Telefacts. Server.dll?8080?IFUs? Server.dll?8080?IFUs? GYNECARE TVT™ Obturator System Tension-Free Support for Incontinence. GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh. Ec.europa. Consumer Reports May 30, 2012 Op-Ed: Medical Device Loophole Leaves Patients At Risk.

Medical Device Loophole Leaves Patients At Risk By James A. Guest President & CEO, Consumer Reports. FDA, Medical Device Makers & Wharton’s Healthcare Management Professors Matthew Grennan & Robert Town. Medical device warranty: an antidote to industry entitlements? Congress is selling out! Medtronic's Covidien to put pelvic mesh cases to bed. FDA gives nod to newest pelvic mesh product, despite ongoing safety issues. MDDI Medical Device and Diagnostic Industry News Products and Suppliers. Implanted Medical Devices.